$HSTM

HEALTHSTREAM INC

1
1
0

No SEC Form 4 filings for $HSTM in the last 30 days.

See all $HSTM insider activity →
Med

HEALTHSTREAM INC (HSTM): Entry into a Material Definitive Agreement

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement On September 10, 2026, HealthStream, Inc., a Tennessee corporation (the “Company”), entered into the Second Amendment to Amended and Restated Revolving Credit Agreement (the “Second Amendment”), dated as of September 10, 2026,

Is HealthStream (HSTM) a Better Healthcare Bet Than Humana (HUM) Right Now?

Humana (HUM) and HealthStream (HSTM) partnered to expand caregiver training. Humana reported Q2 2026 adjusted EPS of $7.61, lowering FY GAAP EPS guidance to $6.52. HealthStream saw Q2 revenue rise 12.5% to $83.7M, with net income up 23.8%. Humana faces regulatory pressures, while HealthStream benefits from strong margins and a debt-free balance sheet.

HealthStream: Q2 Earnings Snapshot

HealthStream Inc. (HSTM) reported Q2 profit of $6.7 million, or 23 cents per share, on revenue of $83.7 million. The company expects full-year revenue of $327 million to $332 million, according to the report.

HSTM sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning HSTM (HEALTHSTREAM INC). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent HSTM coverage spans financial news, earnings and corporate actions.

What's driving HSTM

AlphAI scores every news story that mentions HSTM with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHSTREAM INC's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $HSTM

Score
$HSTMMed

HEALTHSTREAM INC (HSTM): Entry into a Material Definitive Agreement

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement On September 10, 2026, HealthStream, Inc., a Tennessee corporation (the “Company”), entered into the Second Amendment to Amended and Restated Revolving Credit Agreement (the “Second Amendment”), dated as of September 10, 2026,

$HSTMHigh

HEALTHSTREAM INC (HSTM): Results of Operations and Financial Condition

HEALTHSTREAM INC (HSTM) filed an SEC Form 8-K — Results of Operations and Financial Condition. HealthStream Announces Second Quarter 2026 Results Page 1 August 3, 2026 Exhibit 99.1 Contact: Scott A. Roberts Chief Financial Officer (615) 301-3182 ir@healthstream.com Media: Mollie Condra, Ph.D. Head, Investor Relations & Communications (615) 301-3237 mollie.condra@healthstre

HealthStream (NASDAQ:HSTM) Director Sells $50,000.00 in Stock

HealthStream director Linda Rebrovick sold 2,000 shares on June 1 at an average $25.00, for $50,000, according to an SEC filing. After the sale, she owned 54,181 shares. The trade followed a Rule 10b5-1 plan. Separately, HealthStream reported May 4 quarterly EPS of $0.20 on $81.2M revenue and authorized a $10M buyback.

$HSTMMed

HealthStream (NASDAQ:HSTM) Declares Stock Buyback Program

HealthStream (NASDAQ:HSTM) announced that its Board of Directors has approved a stock buyback program of $10.0 million, allowing the repurchase of up to 1.7% of its shares. This decision often signals the board's belief that the company's shares are undervalued. The company also reported strong quarterly earnings, beating analyst expectations, and increased its quarterly dividend.

$HSTMLow

HealthStream: Q4 Earnings Snapshot

HealthStream Inc. (HSTM) reported a net income of $2.5 million for its fourth quarter, translating to 9 cents per share, or 18 cents per share after adjustments. The company, which provides internet-based educational content for healthcare, achieved $79.7 million in revenue for the quarter and $304.1 million for the full year. HealthStream anticipates full-year revenue to be between $323 million and $330 million.

Riverwater Partners Small Cap Strategy Sold Its Stake in HealthStream (HSTM)

Riverwater Partners Small Cap Strategy sold its entire stake in HealthStream (HSTM) during Q4 2025, even though it acknowledges the company's strong healthcare platform. The decision was due to challenges in HealthStream's commercialization efforts, with Riverwater indicating a potential revisit if commercial traction improves. The strategy cited underperformance against the Russell 2000 Index in 2025 and is now prioritizing AI stocks for greater upside potential.

Related tickers